Clin Exp Pediatr.  2023 Mar;66(3):134-141. 10.3345/cep.2022.00703.

Clinical characteristics of pediatric patients infected with SARS-CoV-2 versus common human coronaviruses: a national multicenter study

Affiliations
  • 1Department of Pediatrics, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 2Department of Pediatrics, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea
  • 3Department of Pediatrics, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
  • 4Department of Pediatrics, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea
  • 5Department of Pediatrics, Seoul Medical Center, Seoul, Korea
  • 6Department of Pediatrics, Incheon Medical Center, Incheon Medical Center COVID-19 Medical Response Team, Incheon, Korea
  • 7Department of Pediatrics, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
  • 8SCH Biomedical Informatics Research Unit, Soonchunhyang University Seoul Hospital, Seoul, Korea
  • 9Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul, Korea
  • 10Department of Pediatrics, Dankook University Hospital, Cheonan, Korea
  • 11Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 12Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea
  • 13Department of Pediatrics, Daegu Catholic University Medical Center, Catholic University of Daegu, Daegu, Korea
  • 14Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea
  • 15Department of Pediatrics, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Bundang, Korea
  • 16Department of Pediatrics, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea
  • 17Department of Pediatrics, Samsung Changwon Hospital, Changwon, Korea
  • 18Department of Pediatrics, Wonkwang University School of Medicine, Iksan, Korea
  • 19Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
  • 20Department of Pediatrics, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea
  • 21Department of Pediatrics, CHA University CHA Bundang Medical Center, Seongnam, Korea
  • 22Department of Pediatrics, Childhood Asthma Atopy Center, Environmental Health Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  • 23Department of Pediatrics, Dongguk University Ilsan Hospital, Goyang, Korea

Abstract

Background
Human coronaviruses (HCoV) cause mild upper respiratory infections; however, in 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged, causing an acute respiratory disease pandemic. Coronaviruses exhibit marked epidemiological and clinical differences. Purpose: This study compared the clinical, laboratory, and radiographic findings of children infected with SARS-CoV-2 versus HCoV.
Methods
SARS-CoV-2 data were obtained from the Korea Disease Control and Prevention Agency (KDCA) registry and 4 dedicated coronavirus disease 2019 (COVID-19) hospitals. Medical records of children admitted with a single HCoV infection from January 2015 to March 2020 were collected from 10 secondary/tertiary hospitals. Clinical data included age, sex, underlying disease, symptoms, test results, imaging findings, treatment, and length of hospital stay.
Results
We compared the clinical characteristics of children infected with HCoV (n=475) to those of children infected with SARS-CoV-2 (272 from KDCA, 218 from COVID-19 hospitals). HCoV patients were younger than KDCA patients (older than 9 years:3.6% vs. 75.7%; P<0.001) and patients at COVID-19 hospitals (2.0±2.9 vs 11.3±5.3; P<0.001). Patients with SARS-CoV-2 infection had a lower rate of fever (26.6% vs. 66.7%; P<0.001) and fewer respiratory symptoms than those with HCoV infection. Clinical severity, as determined by oxygen therapy and medication usage, was worse in children with HCoV infection. Children and adolescents with SARS-CoV-2 had less severe symptoms.
Conclusion
Children and adolescents with COVID-19 had a milder clinical course and less severe disease than those with HCoV in terms of symptoms at admission, examination findings, and laboratory and radiology results.

Keyword

Child; Coronavirus; COVID-19; SARS-CoV-2
Full Text Links
  • CEP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr